Citius Oncology CTOR
NASDAQ CTOR
$0.94 +0.01 (+1.17%)
As of: Sep 9, 2026 · 3:59 PM EDT

Citius Oncology (CTOR) Long-Term Debt Issuances (2023 - 2024)

Citius Oncology's (CTOR) quarterly Long-Term Debt Issuances came in at $325311.0 in Q2 2024, up 62.66% quarter-over-quarter from $200000.0 in Q1 2024.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Citius Oncology (CTOR) Long-Term Debt Issuances (2023 - 2024) Analysis & Trends

Citius Oncology (CTOR) has reported Long-Term Debt Issuances for 2 consecutive years, with $325311.0 the latest figure, recorded in Q2 2024.

Peer Set

Peer Comparison

All peers
# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn -
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 1.32 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn -
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn -
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -
10 Citius Oncology 101.41 Mn 101.41 Mn 1.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 325,311.00
Mar 31, 2024 200,000.00
Sep 30, 2023 779,875.00